Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:09:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has updated its treatment timeline, indicating that the average duration of treatment is now specified as 'up to 2 years' and 'average of 4 months' after starting treatment. Additionally, the revision number has been updated from v2.16.1 to v2.16.2.
    Difference
    2%
    Check dated 2025-06-06T09:37:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:30:20.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:59:20.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:51:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Biliary Tract Cancer and its associated study, while significant details regarding the study's inclusion and exclusion criteria have been removed.
    Difference
    32%
    Check dated 2025-04-16T14:44:06.000Z thumbnail image

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.